Follow
emmanuel chartier-kastler
emmanuel chartier-kastler
academic professor of urology, sorbonne université
Verified email at sorbonne-universite.fr
Title
Cited by
Cited by
Year
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study
B Schurch, M de SÈZE, P Denys, E Chartier-Kastler, F Haab, K Everaert, ...
The Journal of urology 174 (1), 196-200, 2005
6902005
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study
H Gacaferi, GS Collaborative, COVIDSurg Collaborative
Anaesthesia 76 (6), 2021
543*2021
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity
A Reitz, M Stöhrer, G Kramer, G Del Popolo, E Chartier-Kastler, J Pannek, ...
European urology 45 (4), 510-515, 2004
5312004
Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review
G Karsenty, P Denys, G Amarenco, M De Seze, X Gamé, F Haab, ...
european urology 53 (2), 275-287, 2008
3402008
Urinary incontinence in French women: prevalence, risk factors, and impact on quality of life
A Lasserre, C Pelat, V Gueroult, T Hanslik, E Chartier-Kastler, T Blanchon, ...
European urology 56 (1), 177-183, 2009
2862009
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm
M Peycelon, V Hupertan, E Comperat, R Renard-Penna, C Vaessen, ...
The Journal of urology 181 (1), 35-41, 2009
2422009
Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia
EJ Chartier-Kastler, JLHR Bosch, M Perrigot, MB CHANCELLOR, ...
The Journal of urology 164 (5), 1476-1480, 2000
2322000
Histologic features in the urinary bladder wall affected from neurogenic overactivity—a comparison of inflammation, oedema and fibrosis with and without injection of botulinum …
E Compérat, A Reitz, A Delcourt, F Capron, P Denys, E Chartier-Kastler
European urology 50 (5), 1058-1064, 2006
1982006
International Continence Society best practice statement for use of sacral neuromodulation
HB Goldman, JC Lloyd, KL Noblett, MP Carey, JC Castaño Botero, ...
Neurourology and urodynamics 37 (5), 1823-1848, 2018
1792018
Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus …
M Oelke, K Becher, D Castro-Diaz, E Chartier-Kastler, M Kirby, A Wagg, ...
Age and ageing 44 (5), 745-755, 2015
1792015
Sacral neuromodulation: standardized electrode placement technique
KE Matzel, E Chartier‐Kastler, CH Knowles, PA Lehur, A Muñoz‐Duyos, ...
Neuromodulation: Technology at the Neural Interface 20 (8), 816-824, 2017
1772017
Focused extracorporeal pyrotherapy
G Vallancien, E Chartier-Kastler, N Bataille, D Chopin, M Harouni, ...
European urology 23 (Suppl. 1), 48-52, 1993
167*1993
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE
B Monz, E Chartier-Kastler, C Hampel, G Samsioe, S Hunskaar, ...
European urology 51 (4), 1073-1082, 2007
1612007
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo …
P Denys, L Le Normand, I Ghout, P Costa, E Chartier-Kastler, P Grise, ...
European urology 61 (3), 520-529, 2012
1602012
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma
M Rouprêt, V Hupertan, O Traxer, G Loison, E Chartier-Kastler, P Conort, ...
Urology 67 (6), 1181-1187, 2006
1572006
Management of neurogenic bladder in patients with multiple sclerosis
V Phe, E Chartier–Kastler, JN Panicker
Nature Reviews Urology 13 (5), 275-288, 2016
1462016
Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up—an …
J Salomon, P Denys, C Merle, E Chartier-Kastler, C Perronne, JL Gaillard, ...
Journal of Antimicrobial Chemotherapy 57 (4), 784-788, 2006
1452006
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection
M Rouprêt, O Traxer, M Tligui, P Conort, E Chartier-Kastler, F Richard, ...
European urology 51 (3), 709-714, 2007
1442007
Principles of sacral nerve stimulation (SNS) for the treatment of bladder and urethral sphincter dysfunctions
MB Chancellor, EJ Chartier-Kastler
Neuromodulation: Technology at the Neural Interface 3 (1), 15-26, 2000
1422000
High‐intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology
X Rebillard, M Soulié, E Chartier‐Kastler, JL Davin, JP Mignard, ...
BJU international 101 (10), 1205-1213, 2008
1342008
The system can't perform the operation now. Try again later.
Articles 1–20